OTC switching program of prescription drugs is only option, KPA president says

Published: 2011-06-21 07:00:00

Updated: 2011-06-21 07:00:00

The Korean Pharmaceutical Association unveiled Friday its plan to switch some prescription medicines into OTC drugs as the subcommittee of the Central Pharmaceutical Affairs Council is to convene on June 21.

“At this juncture, we should show prudence. However, the association will demand that ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK